Colorectal cancer other imaging findings

Colorectal cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Colorectal cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Metastasis Treatment
Primary Prevention
Secondary Prevention
Follow-up
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Colorectal cancer other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Colorectal cancer other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Colorectal cancer other imaging findings
CDC on Colorectal cancer other imaging findings
Colorectal cancer other imaging findings in the news
Blogs on Colorectal cancer other imaging findings
Directions to Hospitals Treating Colorectal cancer
Risk calculators and risk factors for Colorectal cancer other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

PET scan

Cancer cells in the body grow rapidly, so they absorb the radioactive sugar fluorodeoxyglucose or FDG used in Positron emission tomography. Location and extent of the tumor mass can be determined using PET scan.

References

Template:WikiDoc Sources